Biosyent investor
WebNov 16, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that … WebMar 9, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are …
Biosyent investor
Did you know?
WebJun 11, 2024 · A copy of the early warning report will be available under BioSyent’s profile on SEDAR at www.sedar.com, or may be obtained by contacting Ryan Caughey, General Counsel and Corporate Secretary at ... WebShares of BioSyent are available in the United States on the OTC Pink Marketplace under the trading symbol BIOYF. 2. Looking for general information about your shares? All …
WebApr 9, 2024 · The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BioSyent Inc. was incorporated in 2006 and is headquartered in Mississauga, …
WebBioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are … http://www.biosyent.com/rx/home/
WebApr 6, 2024 · BioSyent's mailing address is 170 Attwell Dr Suite 520, ETOBICOKE, ON M9W 5Z5, Canada. The official website for the company is www.biosyent.com. The …
WebFeb 24, 2024 · 1.3% of BioSyent shares are held by institutional investors. 40.6% of BioSyent shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. lambeth event applicationWebNov 15, 2012 · TORONTO, ONTARIO--(Marketwire - Nov 15, 2012) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX) today released a summary of its Third Quarter (Q3) 2012 financial results. - Q3 2012 Sales of $1,575,598 sets an all time quarterly record and grew by 60% over Q3 2011 help 2 month old teethingWebMar 31, 2024 · BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com. This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be … help 2 othershttp://www.biosyent.com/rx/investor_center/ lambeth event appWebMar 31, 2024 · For further information please contact: Mr. René C. Goehrum President and CEO BioSyent Inc. E-Mail: [email protected] Phone: 905-206-0013 Web: www.biosyent.com This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and … lambeth events strategyWebSep 14, 2024 · René Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent’s business and corporate activities. The MicroCap Leadership Summit is attended by retail and ... lambeth ev strategyWebSep 29, 2024 · BioSyent climbed a long way after the early 2024 pandemic pullback. The stock went from about $3.20 to $8.00 before the year was out. But 2024 has been a bit of … help 2 own